uniQure N.V. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights – QURE
FDA reversals leave investors worrying about the fates of other experimental drugs [CNBC]
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
FDA goes on offense amid surge of criticism for recent drug decisions [CNN]